RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Bolivar, MO · +41 more sites
3 recruiting alzheimer's disease studies with a site in Bolivar, MO.
Sponsor: Eli Lilly and Company
Bolivar, MO · +41 more sites
Sponsor: Eli Lilly and Company
Bolivar, MO · +51 more sites
Sponsor: Novartis Pharmaceuticals
Bolivar, MO · +23 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.